Magdolna Dank

5.0k total citations
120 papers, 1.5k citations indexed

About

Magdolna Dank is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Magdolna Dank has authored 120 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 43 papers in Cancer Research and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Magdolna Dank's work include Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (18 papers) and HER2/EGFR in Cancer Research (13 papers). Magdolna Dank is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (18 papers) and HER2/EGFR in Cancer Research (13 papers). Magdolna Dank collaborates with scholars based in Hungary, Germany and United States. Magdolna Dank's co-authors include M. Wenczl, J. Załuski, R. Bugat, Erdem Göker, Vahur Valvere, Attila Marcell Szász, Janina Kulka, Christian Peschel, Laura A. Cisar and Sıddika Songül Yalçın and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Magdolna Dank

115 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdolna Dank Hungary 19 730 499 419 394 242 120 1.5k
Choong‐kun Lee South Korea 21 688 0.9× 490 1.0× 535 1.3× 312 0.8× 351 1.5× 100 1.6k
Akihiko Shimomura Japan 22 1.1k 1.5× 536 1.1× 751 1.8× 537 1.4× 137 0.6× 132 2.0k
Yu Sunakawa Japan 25 1.2k 1.6× 518 1.0× 465 1.1× 341 0.9× 256 1.1× 183 1.8k
Riccardo Giampieri Italy 26 1.3k 1.7× 702 1.4× 687 1.6× 583 1.5× 256 1.1× 122 2.2k
Hiroyuki Takamura Japan 26 993 1.4× 416 0.8× 837 2.0× 453 1.1× 705 2.9× 150 2.5k
Joo Young Kim South Korea 21 932 1.3× 357 0.7× 292 0.7× 178 0.5× 277 1.1× 75 1.8k
J. Pablo Arnoletti United States 28 1.3k 1.8× 532 1.1× 537 1.3× 335 0.9× 807 3.3× 66 2.1k
Nicola Battelli Italy 23 1.0k 1.4× 814 1.6× 512 1.2× 553 1.4× 291 1.2× 91 1.9k
Antonella Spila Italy 25 744 1.0× 319 0.6× 500 1.2× 308 0.8× 163 0.7× 64 1.6k
Luca Faloppi Italy 25 807 1.1× 499 1.0× 580 1.4× 601 1.5× 223 0.9× 92 1.8k

Countries citing papers authored by Magdolna Dank

Since Specialization
Citations

This map shows the geographic impact of Magdolna Dank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdolna Dank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdolna Dank more than expected).

Fields of papers citing papers by Magdolna Dank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdolna Dank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdolna Dank. The network helps show where Magdolna Dank may publish in the future.

Co-authorship network of co-authors of Magdolna Dank

This figure shows the co-authorship network connecting the top 25 collaborators of Magdolna Dank. A scholar is included among the top collaborators of Magdolna Dank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdolna Dank. Magdolna Dank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nyírő, Gábor, Zoltán Herold, János Tibor Fekete, et al.. (2024). Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism. Hypertension. 81(12). 2479–2488. 6 indexed citations
2.
Szentmártoni, Gyöngyvér, et al.. (2024). Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors. Biomedicines. 12(3). 593–593. 5 indexed citations
3.
Garay, Tamás, Magdolna Herold, Alexandra Simon, et al.. (2024). Immune Marker and C-Reactive Protein Dynamics and Their Prognostic Implications in Modulated Electro-Hyperthermia Treatment in Advanced Pancreatic Cancer: A Retrospective Analysis. SHILAP Revista de lepidopterología. 4(4). 385–399. 1 indexed citations
4.
5.
Szász, Attila Marcell, Giammaria Fiorentini, Magdolna Herold, et al.. (2023). Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas. Cancers. 15(3). 880–880. 5 indexed citations
6.
Dank, Magdolna, Magdolna Herold, Zoltán Herold, et al.. (2023). Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases. World Journal of Gastroenterology. 29(18). 2850–2863. 2 indexed citations
7.
Marton, L J, et al.. (2023). The role of stigma and depression in the reduced adherence among young breast cancer patients in Hungary. BMC Psychology. 11(1). 319–319. 2 indexed citations
8.
Somogyi, Anikó, Magdolna Herold, Klára Rosta, et al.. (2022). Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?. Open Medicine. 17(1). 160–173. 3 indexed citations
9.
Kiss, Éva, et al.. (2022). Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line. International Journal of Molecular Sciences. 23(5). 2546–2546. 4 indexed citations
10.
Barták, Barbara Kinga, Alexandra Kalmár, Zsófia Brigitta Nagy, et al.. (2022). A Liquid Biopsy-Based Approach for Monitoring Treatment Response in Post-Operative Colorectal Cancer Patients. International Journal of Molecular Sciences. 23(7). 3774–3774. 17 indexed citations
11.
Kiss, Éva, et al.. (2022). The Effect of Dietary Methyl-Donor Intake and Other Lifestyle Factors on Cancer Patients in Hungary. Cancers. 14(18). 4432–4432. 2 indexed citations
12.
Kiss, Éva, et al.. (2021). Methyl-Donors Can Induce Apoptosis and Attenuate Both the Akt and the Erk1/2 Mediated Proliferation Pathways in Breast and Lung Cancer Cell Lines. International Journal of Molecular Sciences. 22(7). 3598–3598. 10 indexed citations
13.
Molnár, Béla, Orsolya Galamb, Alexandra Kalmár, et al.. (2019). Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update. Expert Review of Molecular Diagnostics. 19(6). 477–498. 30 indexed citations
14.
Avouac, Bernard, Magdolna Dank, Karina Jahnz‐Różyk, et al.. (2017). Real World Evidence In Europe - The Results Of An Expert Survey. Value in Health. 20(9). A655–A655. 1 indexed citations
15.
16.
Mueller, Volkmar, Magdolna Dank, Sabine de Ducla, Lada Mitchell, & Andreas Schneeweiß. (2016). Real-world effectiveness and safety of first-line bevacizumab (BEV) + paclitaxel (PAC) in >2000 patients (pts) with HER2-negative metastatic breast cancer (mBC). Annals of Oncology. 27. vi73–vi73. 1 indexed citations
17.
Madaras, Lilla, Attila Marcell Szász, Anna‐Mária Tõkés, et al.. (2012). [Morphological and immunophenotypical heterogeneity in breast cancers of young and elderly women].. PubMed. 56(2). 75–8. 3 indexed citations
18.
Tõkés, Anna‐Mária, Attila Marcell Szász, Magdolna Dank, et al.. (2009). Stromal Matrix Protein Expression Following Preoperative Systemic Therapy in Breast Cancer. Clinical Cancer Research. 15(2). 731–739. 20 indexed citations
19.
Dank, Magdolna. (2002). The role of aromasin in the hormonal therapy of breast cancer. Pathology & Oncology Research. 8(2). 87–92. 10 indexed citations
20.
Dank, Magdolna. (2001). [Human recombinant anti-HER2 monoclonal antibody--a new targeted treatment in breast cancer].. PubMed. 142(46). 2563–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Choong‐kun Lee Breakdown of academic impact, for papers by Akihiko Shimomura Breakdown of academic impact, for papers by Yu Sunakawa Breakdown of academic impact, for papers by Riccardo Giampieri Breakdown of academic impact, for papers by Hiroyuki Takamura Breakdown of academic impact, for papers by Joo Young Kim Breakdown of academic impact, for papers by J. Pablo Arnoletti Breakdown of academic impact, for papers by Nicola Battelli Breakdown of academic impact, for papers by Antonella Spila Breakdown of academic impact, for papers by Luca Faloppi
Rankless by CCL
2026